• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Polyreactive antibodies in adaptive immune responses to viruses.适应性免疫反应中针对病毒的多反应性抗体。
Cell Mol Life Sci. 2012 May;69(9):1435-45. doi: 10.1007/s00018-011-0872-6. Epub 2011 Nov 2.
2
Polyreactive Antibodies in Anti-HIV-1 Responses.抗 HIV-1 反应中的多反应性抗体。
Curr Mol Med. 2018;18(2):126-133. doi: 10.2174/1566524018666180720165406.
3
Host controls of HIV broadly neutralizing antibody development.宿主对HIV广泛中和抗体产生的控制。
Immunol Rev. 2017 Jan;275(1):79-88. doi: 10.1111/imr.12508.
4
Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.通过基于生物信息学的 CDR 环分析揭示抗体多反应性的生化模式。
Elife. 2020 Nov 10;9:e61393. doi: 10.7554/eLife.61393.
5
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.多反应性广谱中和 B 细胞被选择提供对大流行威胁流感病毒的防御。
Immunity. 2020 Dec 15;53(6):1230-1244.e5. doi: 10.1016/j.immuni.2020.10.005. Epub 2020 Oct 22.
6
Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination.克隆优势:HIV-1感染和疫苗接种免疫反应受限及失败的原因
J Acquir Immune Defic Syndr (1988). 1992;5(11):1158-68.
7
How can polyreactive antibodies conquer rapidly evolving viruses?多反应性抗体如何征服快速进化的病毒?
Trends Immunol. 2021 Aug;42(8):654-657. doi: 10.1016/j.it.2021.06.008. Epub 2021 Jul 7.
8
Glycan Reactive Natural Antibodies and Viral Immunity.糖基反应性天然抗体与病毒免疫。
Viral Immunol. 2020 May;33(4):266-276. doi: 10.1089/vim.2019.0136. Epub 2019 Dec 17.
9
Antibody polyreactivity in health and disease: statu variabilis.抗体的多反应性在健康和疾病中的作用:变化不定的状态。
J Immunol. 2013 Aug 1;191(3):993-9. doi: 10.4049/jimmunol.1300880.
10
Antibody B cell responses in HIV-1 infection.HIV-1 感染中的抗体 B 细胞反应。
Trends Immunol. 2014 Nov;35(11):549-61. doi: 10.1016/j.it.2014.08.007. Epub 2014 Sep 16.

引用本文的文献

1
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.人类免疫缺陷病毒1型包膜糖蛋白:结构、功能及与中和抗体的相互作用
Nat Rev Microbiol. 2025 Jul 23. doi: 10.1038/s41579-025-01206-6.
2
Molecular mechanisms of DNA lesion and repair during antibody somatic hypermutation.抗体体细胞超突变过程中 DNA 损伤与修复的分子机制。
Sci China Life Sci. 2024 Nov;67(11):2344-2353. doi: 10.1007/s11427-024-2615-1. Epub 2024 Jul 23.
3
γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges.γδ T 细胞抗原受体多特异性使 T 细胞能够对广泛的免疫挑战产生反应。
Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2315592121. doi: 10.1073/pnas.2315592121. Epub 2024 Jan 16.
4
Evaluation of Immune Response to Mucosal Immunization with an Oral Probiotic-Based Vaccine in Mice: Potential for Prime-Boost Immunization against SARS-CoV-2.评估口服益生菌疫苗对小鼠黏膜免疫的应答:作为 SARS-CoV-2 初免-加强免疫的潜力。
Int J Mol Sci. 2023 Dec 22;25(1):215. doi: 10.3390/ijms25010215.
5
Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients.新冠疫苗接种者体内的短暂性自身反应性PF4和抗磷脂抗体
Vaccines (Basel). 2023 Dec 14;11(12):1851. doi: 10.3390/vaccines11121851.
6
HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria.HIV-1 治疗时机塑造了人类肠道记忆 B 细胞对共生菌的反应。
Nat Commun. 2023 Oct 10;14(1):6326. doi: 10.1038/s41467-023-42027-6.
7
Discovery medicine - the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine.发现医学——HVTN 开发 HIV-1 广谱中和疫苗的迭代方法。
Curr Opin HIV AIDS. 2023 Nov 1;18(6):290-299. doi: 10.1097/COH.0000000000000821. Epub 2023 Sep 13.
8
Non-specificity as the sticky problem in therapeutic antibody development.非特异性作为治疗性抗体开发中的棘手问题。
Nat Rev Chem. 2022 Dec;6(12):844-861. doi: 10.1038/s41570-022-00438-x. Epub 2022 Nov 14.
9
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.感染 SARS-CoV-2 后针对趋化因子的自身抗体与疾病进程相关。
Nat Immunol. 2023 Apr;24(4):604-611. doi: 10.1038/s41590-023-01445-w. Epub 2023 Mar 6.
10
Mixed Origins: HIV gp120-Specific Memory Develops from Pre-Existing Memory and Naive B Cells Following Vaccination in Humans.混合起源:HIV gp120 特异性记忆在人类接种疫苗后由预先存在的记忆和幼稚 B 细胞产生。
AIDS Res Hum Retroviruses. 2023 Jul;39(7):350-366. doi: 10.1089/AID.2022.0104. Epub 2023 Mar 22.

本文引用的文献

1
Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells.差异调节区分了 IgG+ 人类循环记忆 B 细胞和骨髓浆细胞。
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18044-8. doi: 10.1073/pnas.1113395108. Epub 2011 Oct 24.
2
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.一种强效且广谱的中和抗体可识别并穿透 HIV 聚糖盾牌。
Science. 2011 Nov 25;334(6059):1097-103. doi: 10.1126/science.1213256. Epub 2011 Oct 13.
3
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated.急性感染期 HIV-1 gp41 上的初始抗体结合物具有多反应性和高度突变性。
J Exp Med. 2011 Oct 24;208(11):2237-49. doi: 10.1084/jem.20110363. Epub 2011 Oct 10.
4
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.抗原特异性单个 B 细胞分选分离人抗 HIV gp41 膜近端区中和抗体。
PLoS One. 2011;6(9):e23532. doi: 10.1371/journal.pone.0023532. Epub 2011 Sep 30.
5
Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.从感染 A 型和 B 型病毒的个体中克隆的 HIV-1 gp140 的记忆 B 细胞抗体。
PLoS One. 2011;6(9):e24078. doi: 10.1371/journal.pone.0024078. Epub 2011 Sep 8.
6
Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.在 2F5 VH x VL 敲入小鼠中拯救表达 HIV-1 广谱中和抗体的 B 细胞揭示了多种耐受控制。
J Immunol. 2011 Oct 1;187(7):3785-97. doi: 10.4049/jimmunol.1101633. Epub 2011 Sep 9.
7
Broad neutralization coverage of HIV by multiple highly potent antibodies.多种高效价抗体对 HIV 的广泛中和覆盖。
Nature. 2011 Sep 22;477(7365):466-70. doi: 10.1038/nature10373.
8
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.编码 R620W 变异的 PTPN22 等位基因干扰人类中自身反应性 B 细胞的清除。
J Clin Invest. 2011 Sep;121(9):3635-44. doi: 10.1172/JCI45790. Epub 2011 Aug 1.
9
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.分析 HIV-1 包膜 V2/V3 构象表位特异性广谱中和抗体的克隆谱系及其推断的未突变共同祖先。
J Virol. 2011 Oct;85(19):9998-10009. doi: 10.1128/JVI.05045-11. Epub 2011 Jul 27.
10
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.序列和结构上与 CD4 结合模拟广泛而有效的 HIV 抗体的趋同。
Science. 2011 Sep 16;333(6049):1633-7. doi: 10.1126/science.1207227. Epub 2011 Jul 14.

适应性免疫反应中针对病毒的多反应性抗体。

Polyreactive antibodies in adaptive immune responses to viruses.

机构信息

Laboratory of Molecular Immunology, The Rockefeller University, New York City, NY 10021, USA.

出版信息

Cell Mol Life Sci. 2012 May;69(9):1435-45. doi: 10.1007/s00018-011-0872-6. Epub 2011 Nov 2.

DOI:10.1007/s00018-011-0872-6
PMID:22045557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11114792/
Abstract

B cells express immunoglobulins on their surface where they serve as antigen receptors. When secreted as antibodies, the same molecules are key elements of the humoral immune response against pathogens such as viruses. Although most antibodies are restricted to binding a specific antigen, some are polyreactive and have the ability to bind to several different ligands, usually with low affinity. Highly polyreactive antibodies are removed from the repertoire during B-cell development by physiologic tolerance mechanisms including deletion and receptor editing. However, a low level of antibody polyreactivity is tolerated and can confer additional binding properties to pathogen-specific antibodies. For example, high-affinity human antibodies to HIV are frequently polyreactive. Here we review the evidence suggesting that in the case of some pathogens like HIV, polyreactivity may confer a selective advantage to pathogen-specific antibodies.

摘要

B 细胞在其表面表达免疫球蛋白,作为抗原受体。当作为抗体分泌时,相同的分子是针对病毒等病原体的体液免疫反应的关键要素。尽管大多数抗体仅限于结合特定抗原,但有些是多反应性的,能够与几种不同的配体结合,通常亲和力较低。在 B 细胞发育过程中,生理耐受机制(包括删除和受体编辑)会从库中清除高度多反应性的抗体。然而,低水平的抗体多反应性是被容忍的,并且可以赋予针对病原体特异性抗体的额外结合特性。例如,针对 HIV 的高亲和力人抗体通常是多反应性的。在这里,我们回顾了一些证据,表明在某些病原体(如 HIV)的情况下,多反应性可能会赋予针对病原体的特异性抗体选择性优势。